Financials
- Financial year
- 2022
- Turnover
- €575.8m
- Profit
- €8.5m
- Solvency
- 80.6%
Turnover▲ 34.5%
Net result
20182022
Summary
VWR INTERNATIONAL has been active since 1937 and the Belgian Official Gazette contains no insolvency or warning signals. The 2022 annual accounts show equity of €916.3m and a net result of €8.5m. Equity is growing by about 11% per year across the filed financial years. The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€575.8mturnover 2022
- Staff
- 461.3 FTE
- Equity
- €916.3m
- Profit
- €8.5m
Financial health
- Bankruptcy probabilitywithin 12 months
- 1.3%
2022 figures too old to score
Structure
- Holdings
- 1
- VAN GEEL ChristopheDirector
Auditor: Deloitte Bedrijfsrevisoren/Réviseurs d’EntreprisesAccounts 36 days early11 of 41 deeds read
Signalsraises riskFigures for financial year 2022 (filed 11-07-2023)Liquidity: current ratio 3.25, cash €232,036lowers riskSize: turnover €575.8m, 461.3 FTE, total assets €1.14bnFounded in 1937neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
No current score
Figures too old
The available figures for FY 2022 are too old to assess current financial health.
Financial strength, FY 2022 · tick = 2019
Strong
Solvency
100=
equity 80.6% of total assets
Liquidity
49=
short-term debt 11.0% · cash 0.0%
Profitability
40-1
return on assets 0.7%
Bankruptcy probability, 12 months
1.3%
Low
0%0.5%1.5%4%10%≥ 25%
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.8%lowest value
12-2024: 0.9%▲ +0.1 percentage points vs 11-2024
01-2025: 1.5%▲ +0.6 percentage points vs 12-2024highest value
02-2025: 1.5%● unchanged vs 01-2025highest value
03-2025: 1.5%● unchanged vs 02-2025highest value
04-2025: 1.3%▼ -0.2 percentage points vs 03-2025
05-2025: 1.3%● unchanged vs 04-2025
06-2025: 1.3%● unchanged vs 05-2025
07-2025: 1.3%● unchanged vs 06-2025
08-2025: 1.3%● unchanged vs 07-2025
09-2025: 1.3%● unchanged vs 08-2025
10-2025: 1.3%● unchanged vs 09-2025
11-2025: 1.3%● unchanged vs 10-2025
12-2025: 1.3%● unchanged vs 11-2025
01-2026: 1.3%● unchanged vs 12-2025
02-2026: 1.3%● unchanged vs 01-2026
03-2026: 1.3%● unchanged vs 02-2026
04-2026: 1.3%● unchanged vs 03-2026
05-2026: 1.3%● unchanged vs 04-2026
06-2026: 1.3%● unchanged vs 05-2026
07-2026: 1.3%● unchanged vs 06-2026
08-2026: 1.3%● unchanged vs 07-2026
09-2026: 1.3%● unchanged vs 08-2026
10-2026: 1.3%● unchanged vs 09-2026
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
36 days early
2024
2 days early
2023
22 days early
2022
25 days early
2021
17 days early
2020
24 days early
2019
3 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 18 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
20-10-2026 today31-12-2026 year end31-07-2027 deadline
- Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Resignation: Johanna Houben (director) ·…
- Capital & shares · Amendment of…Capital increase · Share issue…
- Annual accounts filedfinancial year 2025 · full…
Key points
By topic
Board & ownership
- Board
- 1 member
- Auditor
- Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
- VAN GEEL ChristopheDirector
Network & group
- Subsidiaries
- 1
- Connected companies
- 1
1 subsidiary
Timeline
- Events
- 67
- Since
- 1978
- Next accounts
- by 31-07-2027
- 08-06-2026Capital & shares · Amendment of the…
- 09-04-2026Resignations & appointments
- 02-10-2025Amendment of the articles
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 01-01-1937
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 11
- Who signs
- Each director alone
- Annual meeting
- Second Monday of May at 15:00
- Purpose
- “De aankoop, verkoop, bewerking en fabricatie van alle toebehoren voor laboratoria en…” (deed in Dutch)
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies Which other companies belong to the same group?VWR INTERNATIONAL · 2 companies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.